Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temsirolimus in Patients With Solid Tumors With <i>PIK3CA</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

JCO precision oncology·2026
Same author

Use of an Integrative Genomics Approach to Identify Metastatic NSCLC Patients Benefiting From the Addition of Chemotherapy to Immune Checkpoint Inhibitors.

Clinical lung cancer·2026
Same author

Perceived Barriers and Facilitators to Physical Activity Engagement Among Cancer Survivors: A Qualitative Study.

Cancers·2026
Same author

Ixazomib triggers autophagic degradation of MUC5AC/integrin-β4 and inhibits non-small cell lung cancer progression.

Cancer letters·2026
Same author

NR4A2 induces perineural invasion in head and neck squamous cell carcinoma and pancreatic ductal adenocarcinoma via CXCL5/CXCR2 signaling axis.

Cancer letters·2026
Same author

Programmed death-ligand 1 expression is associated with local invasion and distant metastases in differentiated thyroid cancer: Systematic review and meta-analysis.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2026

Related Experiment Video

Updated: Mar 15, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K

Resected small cell lung cancer-time for more?

Alissa S Marr1, Chi Zhang2, Apar Kishor Ganti3

  • 1Division of Oncology-Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA ;

Journal of Thoracic Disease
|September 14, 2016
PubMed
Summary

For small cell lung cancer (SCLC) presenting as a solitary pulmonary nodule, adjuvant chemotherapy or chemotherapy with brain radiation after surgery significantly improves survival. These findings aid treatment decisions for resected SCLC patients.

Keywords:
Small cell lung cancer (SCLC)adjuvant chemotherapysurgerysurvival

More Related Videos

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

254
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

11.2K

Related Experiment Videos

Last Updated: Mar 15, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

254
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

11.2K

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Medical Oncology

Background:

  • Small cell lung cancer (SCLC) typically presents with metastatic disease.
  • A small subset of SCLC patients (approx. 4%) may present with a solitary pulmonary nodule, amenable to surgical resection per NCCN guidelines.
  • The role of adjuvant systemic therapy following surgical resection for these early-stage SCLC patients remains underexplored due to a lack of prospective trials.

Discussion:

  • A National Cancer Database analysis suggests adjuvant chemotherapy alone or combined with brain radiation improves survival in resected SCLC.
  • The hazard ratios indicate a significant survival benefit for both adjuvant chemotherapy regimens compared to surgery alone.
  • Given the unlikelihood of future randomized trials, these retrospective data are crucial for clinical decision-making.

Key Insights:

  • Adjuvant chemotherapy following surgical resection is associated with improved survival in select small cell lung cancer patients.
  • The addition of brain radiation to adjuvant chemotherapy further enhances survival benefits.
  • Retrospective data analysis provides valuable evidence for treatment strategies in early-stage SCLC.

Outlook:

  • Further research into optimal adjuvant systemic therapy for resected SCLC is warranted.
  • These findings may influence current treatment guidelines for early-stage SCLC.
  • The study highlights the importance of retrospective data analysis in the absence of prospective trials.